Recombinant SOX9 antibody (AA 393-508)
Quick Overview for Recombinant SOX9 antibody (AA 393-508) (ABIN7470674)
Target
See all SOX9 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 393-508
-
Purpose
- SOX9 antibody (709R)
-
Immunogen
- Recombinant humanSOX9 protein fragment (around aa 393- 508) (exact sequence is proprietary)
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC 1:100-1:200
-
Comment
-
Positive Control: Colon: A strong SOX9 immunostaining should be seen in epithelial cells of the crypt base.
Product Description: SOX9 antibody validated for immunohistochemistry on 76 different Normal Tissues
Negative Control: Colon: SOX9 immunostaining should be absent in all non-epithelial cell types (except few cells in lymphoid germinal centres - if present).
-
Protocol
- Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 ° C. Antibody is stable for 24 months. Non- hazardous.
-
Expiry Date
- 24 months
-
-
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Alternative Name
- SOX9
-
Background
- Gene Alias: Campomelic Dysplasia Autosomal Sex Reversal (CMD1), SRA1, SRXX2, SRY (sex determining region Y) box 9, SRY related HMG box gene 9, Transcription factor SOX9
-
UniProt
- P48436
-
Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
Target
-